Have pharmaceutical companies managed to cash in on the pandemic

covid -19 vaccineswere supposed to bring a lot of income to their developers: states around the world were ready to spend money to return the economy to normal.Have pharmaceutical companies managed to make money and what happens to them after the pandemic?

In 2021, the pharmaceutical companies that pioneered CORONAVIRUS vaccines saw their revenues skyrocket. Now, despite the next increase in the incidence, the rush demand for vaccinations has subsided, and unused vaccines are being prepared for destruction.

Compensate for financial losses with new drugs will not work. Monkeypox does not seem to make money: a vaccine for it already exists, and WHO has not recommended mass vaccination against it. What awaits the heroes of 2021 financially and what is the best thing for investors to do with their papers?